Jorg Weiser Net Worth

The estimated Net Worth of Jorg Weiser is at least $9.55 Milion dollars as of 1 April 2021. Mr. Weiser owns over 418 units of Schrodinger stock worth over $2,417,533 and over the last 4 years he sold SDGR stock worth over $7,133,734. In addition, he makes $0 as Executive Vice President a Managing Director at Schrodinger.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Weiser SDGR stock SEC Form 4 insiders trading

Jorg has made over 3 trades of the Schrodinger stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 418 units of SDGR stock worth $1,814 on 1 April 2021.

The largest trade he's ever made was selling 70,986 units of Schrodinger stock on 16 March 2021 worth over $5,790,328. On average, Jorg trades about 29,262 units every 7 days since 2021. As of 1 April 2021 he still owns at least 117,470 units of Schrodinger stock.

You can see the complete history of Mr. Weiser stock trades at the bottom of the page.

Jorg Weiser biography

DR. Jorg Weiser serves as Executive Vice President, Managing Director of the Company. Mr. Weiser has served as the executive vice president and managing director of our German office and wholly owned subsidiary, Schrödinger GmbH, since October 2002. Dr. Weiser previously served as co-founder and managing director at Anterio Consult & Research GmbH, a German consulting and research company, from June 1999 to September 2002. Dr. Weiser received a doctorate in Organic Chemistry from the University of Göttingen and was a post-doctoral fellow at Columbia University.

How old is Jorg Weiser?

Jorg Weiser is 52, he's been the Executive Vice President a Managing Director of Schrodinger since 2002. There are 12 older and 8 younger executives at Schrodinger. The oldest executive at Schrodinger, Inc. is Dr. Richard A. Friesner, 68, who is the Co-Founder, Scientific Advisory Chairman and Director.

What's Jorg Weiser's mailing address?

Jorg's mailing address filed with the SEC is C/O SCHRODINGER, INC.,, 120 WEST 45TH STREET, 17TH FLOOR, NEW YORK, NY, 10036.

Insiders trading at Schrodinger

Over the last 5 years, insiders at Schrodinger have traded over $1,009,056,149 worth of Schrodinger stock and bought 838,235 units worth $14,249,995 . The most active insiders traders include & Melinda Gates Foundation ..., David E Schrodinger Equity ... a Michael Lynton. On average, Schrodinger executives and independent directors trade stock every 10 days with the average trade being worth of $2,459,207. The most recent stock trade was executed by Kenneth Patrick Lorton on 6 March 2024, trading 5,574 units of SDGR stock currently worth $24,191.

What does Schrodinger do?

Schrödinger, Inc., together with its subsidiaries, provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Complete history of Mr. Weiser stock trades at Schrodinger

Schrodinger executives and stock owners

Schrodinger executives and other stock owners filed with the SEC include:

• Dr. Ramy Farid Ph.D.,
  CEO, Pres & Director
• Yvonne Tran Esq.,
  Exec. VP, Chief Legal Officer & Sec.
• Dr. Karen Akinsanya Ph.D.,
  Exec. VP, Chief Biomedical Scientist and Head of Discovery R&D
• Ramy Farid,
  President, Chief Executive Officer, Director
• Cony D cruz,
  Executive Vice President - Chief Business Officer
• Yvonne Tran,
  Executive Vice President, Chief Legal Officer
• Dr. Richard A. Friesner,
  Co-Founder, Scientific Advisory Chairman and Director
• Richard Friesner,
  Independent Director
• Nancy Thornberry,
  Independent Director
• Gary Sender,
  Independent Director
• Rosana Kapeller-Libermann,
  Independent Director
• Timothy Wright,
  Independent Director
• Shane Brauner,
  Senior Vice President, Chief Information Officer
• Kenneth Lorton,
  Senior Vice President, Chief Technology Officer
• Karen Akinsanya,
  Executive Vice President, Chief Biomedical Scientist, Head of Discovery R&D
• Robert Abel,
  Executive Vice President - science
• Jorg Weiser,
  Executive Vice President, Managing Director
• Jennifer Daniel,
  Chief Human Resource Officer, Senior Vice President
• Joel Lebowitz,
  Executive Vice President, Chief Financial Officer
• Michael Lynton,
  Independent Chairman of the Board of Directors
• Michelle Byington,
  VP of HR
• Jennifer Mayer Daniel,
  Sr. VP & Chief HR Officer
• Jaren Irene Madden,
  Sr. VP of Investor Relations & Corp. Communications
• Shane Brauner,
  Exec. VP & Chief Information Officer
• Kenneth Patrick Lorton,
  Exec. VP & CTO
• Prof. William Goddard III,
  Co-Founder & Scientific Advisor
• Charles Ardai,
  10% owner
• Geoffrey Craig Porges,
  EVP & CFO
• David E Shaw,
  10% owner
• Gary L Ginsberg,
  Director
• Jeffrey Chodakewitz,
  Director
• & Melinda Gates Foundation ...,
  10% owner
• David E Schrodinger Equity ...,
  
• James E Deerfield Mgmt Iv, ...,
  
• Jenny Herman,
  SVP & Controller
• Arun Oberoi,
  Director
• Margaret Dugan,
  Chief Medical Officer